Gastrointestinal Stromal Tumors 
Welcome,         Profile    Billing    Logout  

3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gastrointestinal Stromal Tumors
NCT01646593: Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy

No Longer Available
N/A
US
Regorafenib (BAY73-4506)
Bayer
Gastrointestinal Stromal Tumors
 
 
NCT01613053: Continuation of Drug Supply in Chinese Patients After CAMN107DBR01study Termination

No Longer Available
N/A
RoW
Glivec
Novartis Pharmaceuticals
Gastrointestinal Stromal Tumor
 
 
NCT01689376: Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy (Managed Access Program)

No Longer Available
N/A
RoW
Regorafenib (BAY73-4506)
Bayer
Gastrointestinal Stromal Tumors
 
 

Download Options